文献速递慢性肾脏病血液净化与透析

肾单位体积增大与肾硬化可独立于肾功能预测根治性肾切除术后CKD进展与死亡

Larger Nephron Size and Nephrosclerosis Predict Progressive CKD and Mortality after Radical Nephrectomy for Tumor and Independent of Kidney Function.
PubMed 文献 · J Am Soc Nephrol · 2020-09-16

该研究对936例因肿瘤行根治性肾切除术的患者进行肾脏皮质大楔形切片形态计量分析,中位随访6.4年。结果发现肾小球体积增大、每个肾小球对应的皮质体积增大、全球硬化肾小球比例升高及IF/TA均预测CKD进展,IF/TA还预测非癌死亡,且独立于eGFR等临床因素。

要点

  • 肾小球体积增大与肾硬化可独立于肾功能预测根治性肾切除术后CKD进展。
  • IF/TA比例升高还预测非癌死亡,但不预测癌症死亡或复发。
  • 肾脏形态计量分析有助于识别术后远期非癌临床事件高风险患者。

核心结论

  • 根治性肾切除术后,肾单位增大和肾硬化预测CKD进展,IF/TA预测非癌死亡。
  • 肾脏形态计量分析可预测根治性肾切除术后远期的非癌临床事件。

研究设计与样本

  • 研究纳入936例因肿瘤行根治性肾切除术的患者,取肿瘤远端肾脏皮质大楔形切片进行染色和高分辨率扫描。
  • 对皮质和所有肾小球进行标注,计算肾小球体积、每个肾小球对应的皮质体积、全球硬化肾小球百分比、动脉管腔狭窄百分比及皮质IF/TA百分比。
  • 每6-12个月随访,定义CKD进展为透析、肾移植或肾切除术后eGFR下降40%。
  • 采用Cox模型校正年龄、性别、BMI、高血压、糖尿病、吸烟、eGFR和蛋白尿。

主要发现

  • 中位随访6.4年期间,发生117例CKD进展事件、183例非癌死亡和116例癌症死亡。
  • 肾小球体积增大、每个肾小球对应的皮质体积增大、全球硬化肾小球百分比升高或IF/TA百分比升高均预测CKD进展。
  • IF/TA百分比升高还预测非癌死亡。
  • 肾脏微结构特征不预测癌症死亡或复发。

关键数值与推荐

  • 患者平均年龄64岁,肾切除术后基线eGFR为48 ml/min per 1.73 m2。
  • CKD进展定义为透析、肾移植或肾切除术后eGFR下降40%。
  • 中位随访6.4年。

临床怎么用

  • 对根治性肾切除术后的患者,可考虑肾脏形态计量分析以识别CKD进展和非癌死亡高风险者。
  • 肾小球体积增大、全球硬化肾小球比例升高及IF/TA比例升高提示需加强术后肾功能监测。

局限性

  • 研究仅纳入因肿瘤行根治性肾切除术的患者,结果可能不适用于其他人群。
  • 原文未报告形态计量测量的可重复性或读者间变异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nephron hypertrophy and nephrosclerosis may be important determinants of CKD and mortality. However, studies of outcomes associated with these microstructural features have been limited to small tissue specimens from patients selected for either good kidney health or known kidney disease. METHODS: To determine whether microstructural features are predictive of progressive CKD and mortality outcomes, we studied patients who underwent a radical nephrectomy for a tumor. Large wedge sections of renal parenchyma distal to the tumor were stained and scanned into high-resolution images; we annotated the cortex and all glomeruli to calculate glomerular volume, cortex volume per glomerulus, and percentage of globally sclerotic glomeruli. Morphometric measurements also included percentages of artery luminal stenosis and interstitial fibrosis/tubular atrophy (IF/TA) of the cortex. At follow-up visits every 6-12 months, we determined which patients experienced progressive CKD (defined as dialysis, kidney transplantation, or a 40% decline from postnephrectomy eGFR). Cox models for these outcomes were adjusted for age, sex, body mass index, hypertension, diabetes, smoking, eGFR, and proteinuria. RESULTS: Among 936 patients (mean age, 64 years; postnephrectomy baseline eGFR, 48 ml/min per 1.73 m2), 117 progressive CKD events, 183 noncancer deaths, and 116 cancer deaths occurred during a median follow-up of 6.4 years. Larger glomerular volume, larger cortex per glomerulus, and higher percentage of globally sclerotic glomeruli or IF/TA predicted progressive CKD. Higher percentage IF/TA also predicted noncancer mortality. Microstructural features did not predict cancer mortality or recurrence. CONCLUSIONS: After a radical nephrectomy, larger nephrons and nephrosclerosis predicted progressive CKD, and IF/TA predicted noncancer mortality. Morphometric analysis of renal parenchyma can predict noncancer clinical events in patients long after their radical nephrectomy.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Denic A, Elsherbiny H, Mullan AF, et al. Larger Nephron Size and Nephrosclerosis Predict Progressive CKD and Mortality after Radical Nephrectomy for Tumor and Independent of Kidney Function. J Am Soc Nephrol. 2020. PMID: 32938650. doi:10.1681/ASN.2020040449

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。